ストックスクリーナーアプリを入手
73.26
1.84%
-1.37
アフターアワーズ：
73.13
-0.13
-0.18%
前日終値:
$74.63
開ける：
$73.89
24時間の取引高:
212.60K
Relative Volume:
0.69
時価総額：
$718.83M
収益：
-
当期純損益:
$-19.80M
株価収益率:
-29.99
EPS:
-2.4426
ネットキャッシュフロー:
$-14.56M
1週間 パフォーマンス:
+2.71%
1か月 パフォーマンス:
+4.36%
6か月 パフォーマンス:
-5.77%
1年 パフォーマンス:
+116.94%
1日の値動き範囲:
$71.34
$74.49
1週間の範囲:
$68.80
$75.50
52週間の値動き範囲:
$31.98
$123.75
Bright Minds Biosciences Inc Stock (DRUG) Company Profile
Compare DRUG vs VRTX, REGN, ARGX, RVMD, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DRUG
Bright Minds Biosciences Inc
|
73.26 | 705.59M | 0 | -19.80M | -14.56M | -2.4426 |
VRTX
Vertex Pharmaceuticals Inc
|
477.10 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
762.63 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
853.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
187.53 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
316.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Bright Minds Biosciences Inc Stock (DRUG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-13 | 開始されました | Jefferies | Buy |
| 2025-09-08 | 開始されました | BTIG Research | Buy |
| 2025-05-13 | 開始されました | TD Cowen | Buy |
| 2025-05-07 | 開始されました | Chardan Capital Markets | Buy |
| 2025-01-23 | 開始されました | Piper Sandler | Overweight |
| 2025-01-10 | 開始されました | Cantor Fitzgerald | Overweight |
| 2025-01-10 | 開始されました | H.C. Wainwright | Buy |
| 2024-11-26 | 開始されました | Robert W. Baird | Outperform |
すべてを表示
Bright Minds Biosciences Inc (DRUG) 最新ニュース
Bright Minds Biosciences Inc (DRUG) Cash Flow - TradingKey
40,000 Shares in Bright Minds Biosciences Inc. $DRUG Acquired by Orbimed Advisors LLC - MarketBeat
Bright Minds Biosciences Inc (DRUG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bright Minds Biosciences Inc (DRUG) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bright Minds Biosciences Inc (DRUG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bright Minds Biosciences Inc (DRUG) Institutional Confidence - TradingKey
DRUG|Bright Minds Biosciences Inc|Price:71.840|Chg%:+0.510 - TradingKey
Bright Minds Biosciences Inc (DRUG) Balance Sheet - TradingKey
Wall Street Analysts See a 107.53% Upside in Bright Minds Biosciences Inc. (DRUG): Can the Stock Really Move This High? - Yahoo Finance
Wall Street Analysts See a 27.16% Upside in Unity Software (U): Can the Stock Really Move This High? - Zacks Investment Research
Walleye Capital LLC Has $3.92 Million Holdings in Bright Minds Biosciences Inc. $DRUG - MarketBeat
Bright Minds Biosciences (NASDAQ:DRUG) Upgraded at Zacks Research - MarketBeat
All You Need to Know About Bright Minds Biosciences Inc. (DRUG) Rating Upgrade to Strong Buy - Yahoo Finance
Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
Bright Minds Biosciences (NASDAQ:DRUG) Shares Up 5%Should You Buy? - MarketBeat
Eli Lilly deal to buy AtaiBeckley (psychedelic) - KuCoin
Wall Street Analysts See a 27.35% Upside in Harmony Biosciences (HRMY): Can the Stock Really Move This High? - Yahoo Finance
Bright Minds Biosciences (DRUG) Climbs 2.55% as Bullish Momentum Builds Near Key ResistanceConversion Trade - dars.gov.et
Draig bags another $65M to speed testing of brain drugs - Yahoo Finance
Understanding Momentum Shifts in (DRUG) - Stock Traders Daily
Bright Minds Biosciences (NASDAQ:DRUG) Shares Down 7.7%What's Next? - MarketBeat
Bright Minds Biosciences Inc Company Profile & Introduction - Moomoo
Epilepsy Pipeline Expands as 75+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com
Form 13D/A BRIGHT MINDS BIOSCIENCES INC. For: 2 July By Investing.com - Investing.com Canada
Ian McDonald reports 13.6% Bright Minds (DRUG) ownership stake - Stock Titan
Best TSX Healthcare Stocks to Watch for July 2026 - Kalkine Media
Avoiding Lag: Real-Time Signals in (DRUG) Movement - Stock Traders Daily
Canadian Securities Exchange Reports January 2026 Performance Figures - The Canadian Securities Exchange (CSE)
Bright Minds Biosciences (DRUG) Surges 3.51%, Testing Resistance at $75.19Equity Put Call - dars.gov.et
Indivior Pharmaceuticals Inc. (INDV) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
BrightSpring Health Services, Inc. (BTSG) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
Bright Minds Biosciences Inc (DRUG) Stock Forum and Discussion - Moomoo
Bright Minds Biosciences (DRUG) Surges 3.38% as Shares Approach Resistance at $69.08On Balance Volume - dars.gov.et
DRUG Forecast — Price Target — Prediction for 2027 - TradingView
Bright Minds Biosciences Inc. Actuals & Estimates (CSE:DRUG) - TradingView
Bright Minds Biosciences Inc. (DRUG) Shows Modest Uptick, Testing Key ResistanceGap Fill Strategy - dars.gov.et
$ENA Forecast — Price Prediction for 2026. Should I Buy $ENA? - Intellectia AI
Bright Minds Biosciences (DRUG) Edges Lower Near Resistance Amid Quiet TradingHull Moving Average - dars.gov.et
DRUG Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
Income Statement - Intellectia AI
DRUG Technical Analysis & Stock Price Forecast - Intellectia AI
Discipline and Rules-Based Execution in DRUG Response - Stock Traders Daily
Bright Minds Biosciences (DRUG) Advances 1.92% as Stock Tests Key ResistanceHigh Volume Node - dars.gov.et
Bright Minds Biosciences Inc (DRUG) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Bright Minds Biosciences Inc (DRUG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bright Minds Biosciences Inc - TradingKey
Bright Minds Biosciences Inc (DRUG) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bright Minds Biosciences (DRUG) Slips Slightly, Consolidating Near Key Support LevelsMonthly Profile - dars.gov.et
Bright Minds Biosciences Inc (DRUG) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Bright Minds Biosciences (DRUG) Slides 1% as Buyers and Sellers Battle Near Critical LevelsBull Flag - newsline.com
Bright Minds Biosciences Inc (DRUG) 財務データ
収益
当期純利益
現金流量
EPS
2.44%
0.02%
大文字化:
|
ボリューム (24 時間):